Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.

Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand ...

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

Shares in Bristol-Myers Squibb traded about 2.7% lower Thursday after the drug maker gave 2025 guidance that undershot ...

The move comes less than a year after the company attempted to save $1.5 billion through the layoff of some 2,200 employees.

Bristol Myers Squibb is ending work on a handful of assets, including an immunology medication that was in two Phase 3 trials ...

Bristol Myers walloped sales views Thursday, but Bristol Myers Squibb stock took a hit on a light outlook hamstrung by ...

We will only be able to access your results if the following information exactly matches the information you provided on your UCAS application: UCAS personal ID Surname Date of birth You have ticked ...

Lidl has launched a new 99p that it claims has multiple health benefits. It claims its Solevita Collagen Shot is already a viral hit on social media, with more than 6.2m posts on TikTok, resulting ...

Toby Myers, longtime bassist for John Mellencamp and the Todd Rundgren-discovered band Roadmaster, died on Jan. 16 at age 75. “Sadness has entered the Mellencamp band and John over the passing ...